Histamine regulation of hyperplastic and neoplastic cell growth in cholangiocytes

doi:10.4291/wjgp.v1.i2.38

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 1, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6152)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

408

HTML

4883

Figures (1-4)

607

Tables (1-1)

254

Sum=6152

Jun 15, 2010 (publication date) through Dec 3, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pathophysiology

ISSN

2150-5330

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastrointest Pathophysiol. Jun 15, 2010; 1(2): 38-49
Published online Jun 15, 2010. doi: 10.4291/wjgp.v1.i2.38

Histamine regulation of hyperplastic and neoplastic cell growth in cholangiocytes

Paolo Onori, Eugenio Gaudio, Antonio Franchitto, Gianfranco Alpini, Heather Francis

Paolo Onori, Experimental Medicine, University of L'Aquila, L'Aquila 67100, Italy

Eugenio Gaudio, Antonio Franchitto, Department of Human Anatomy, University of Rome “La Sapienza”, Rome 00161, Italy

Gianfranco Alpini, Research, Central Texas Veterans Health Care System, TX 76504, United States

Gianfranco Alpini, Heather Francis, Scott and White Digestive Disease Research Center, Scott and White, Temple, TX 76504, United States

Gianfranco Alpini, Heather Francis, Division of Gastroenterology, Department of Medicine, Texas A&M Health Science Center, College of Medicine, Temple, TX 76504, United States

Heather Francis, Division of Research and Education, Scott and White, Temple, TX 76504, United States

Author contributions: Onori P and Gaudio E performed literature searches, contributed conceptually to the writing and reviewing of the article; Franchitto A contributed to the production of technical data and reviewed the article; Alpini G contributed conceptually to the article design and reviewed the article; and Francis H performed literature searches, contributed conceptually to the article design, wrote, reviewed and edited the paper.

Correspondence to: Heather Francis, BS, Graduate Student and Research Associate, Texas A&M College of Medicine and Scott and White Hospital 702 SW H.K. Dodgen Loop, Temple, TX 76504, United States. hfrancis@tamu.edu

Telephone: +1-254-7427055

Received: February 9, 2010
Revised: April 3, 2010
Accepted: April 10, 2010
Published online: June 15, 2010

Abstract

Histamine has long been known to be involved in inflammatory events. The discovery of antihistamines dates back to the first half of the 20^th century when a Swiss-Italian pharmacologist, Daniel Bovet began his work. In 1957 he was awarded a Nobel Prize for his production of antihistamines for allergy relief. Since that time, histamine has been found to play a role in other events besides allergic reaction. Possibly unbelievable to Bovet and his peers, histamine has now been marked as playing a role in liver pathologies including hepatobiliary diseases.

Keywords: Histamine; Receptors; Cholangiocytes; Cholestasis; Cholangiocarcinoma